All In Biotech

Free tool

FAERS Monitor: Forteo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021318 or its brand name (Forteo, Teriparatide). Reports on generic versions are filed under their own applications.

Reports

112,496

Serious

41,897

37% of reports

Hospitalization

24,294

Death reported

5,314

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea9,026
  • arthralgia8,725
  • pain in extremity8,375
  • dizziness8,337
  • fall7,933
  • pain7,575
  • fatigue7,225
  • back pain5,948
  • muscle spasms5,753
  • malaise5,689
  • headache5,528
  • asthenia5,454
  • injection site erythema5,069
  • injection site pain4,845
  • injection site bruising4,794

Reports by year received

View as table
YearReports
20046,414
20054,792
20062,193
20072,193
20082,133
20093,068
20103,799
20115,405
20126,250
20132,648
20141,297
201544,975
20162,140
20174,040
20184,898
20194,011
20201,957
20211,813
20221,581
20231,757
20241,839
20252,090
20261,203

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,941,663 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
injection site bruisingSignal4,79411.911.645,102
injection site erythemaSignal5,0697.97.729,578
muscle spasmsSignal5,7536.05.923,519
pain in extremitySignal8,3755.45.329,905
back painSignal5,9484.94.818,110
fallSignal7,9334.54.421,722
arthralgiaSignal8,7254.03.919,490
dizzinessSignal8,3373.23.112,405
injection site painSignal4,8453.02.96,383
astheniaSignal5,4542.72.76,032
malaiseSignal5,6892.42.44,891
painSignal7,5752.32.35,798
nauseaSignal9,0262.12.15,668
fatigue7,2251.71.72,348
headache5,5281.71.61,461

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.